Levonadifloxacin, a Novel Benzoquinolizine Fluoroquinolone, Modulates Lipopolysaccharide-Induced Inflammatory Responses in Human Whole-Blood Assay and Murine Acute Lung Injury Model
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A novel fluoroquinolone called levonadifloxacin has been studied for its effects on inflammatory responses. The compound has been tested in a human whole-blood assay and a murine acute lung injury model, where it modulated lipopolysaccharide-induced inflammatory responses. The results of these studies suggest that levonadifloxacin may have anti-inflammatory properties.